-
Something wrong with this record ?
A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock
D. Rob, R. Špunda, J. Lindner, V. Rohn, J. Kunstýř, M. Balík, J. Rulíšek, P. Kopecký, M. Lipš, O. Šmíd, T. Kovárník, F. Mlejnský, A. Linhart, J. Bělohlávek,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Medline Complete (EBSCOhost)
from 2000-03-01 to 1 year ago
Wiley Free Content
from 1999 to 1 year ago
PubMed
28470920
DOI
10.1002/ejhf.852
Knihovny.cz E-resources
- MeSH
- Angiography MeSH
- Hemodynamics physiology MeSH
- Shock, Cardiogenic etiology physiopathology therapy MeSH
- Humans MeSH
- Extracorporeal Membrane Oxygenation methods MeSH
- Follow-Up Studies MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Ventricular Septal Rupture complications diagnosis physiopathology MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS: Ventricular septal rupture (VSR) became a rare mechanical complication of myocardial infarction in the era of percutaneous coronary interventions but is associated with extreme mortality in patients who present with cardiogenic shock (CS). Promising outcomes have been reported with the use of circulatory support allowing haemodynamic stabilization, followed by delayed repair. Therefore, we analysed our experience with an early use of Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO) for postinfarction VSR. METHODS AND RESULTS: We conducted a retrospective search of institutional database for patients presenting with postinfarction VSR from January 2007 to June 2016. Data from 31 consecutive patients (mean age 69.5 ± 9.1 years) who were admitted to hospital were analysed. Seven out of 31 patients with VSR who were in refractory CS received V-A ECMO support preoperatively. ECMO improved end-organ perfusion with decreased lactate levels 24 hours after implantation (7.9 mmol/L vs. 1.6 mmol/L, p = 0.01), normalized arterial pH (7.25 vs. 7.40, p < 0.04), improved mean arterial pressure (64 mmHg vs. 83 mmHg, p < 0.01) and lowered heart rate (115/min vs. 68/min, p < 0.01). Mean duration of ECMO support was 12 days, 5 out of 7 patients underwent surgical repair, 4 were weaned from ECMO, 3 survived 30 days and 2 survived more than 1 year. The most frequent complication (5 patients) and the cause of death (3 patients) was bleeding. CONCLUSIONS: Our experience suggests that early V-A ECMO in patients with VSR and refractory CS might prevent irreversible multiorgan failure by improved end-organ perfusion. Bleeding complications remain an important limitation of this approach.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010602
- 003
- CZ-PrNML
- 005
- 20180528160638.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ejhf.852 $2 doi
- 035 __
- $a (PubMed)28470920
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rob, Daniel $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 245 12
- $a A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock / $c D. Rob, R. Špunda, J. Lindner, V. Rohn, J. Kunstýř, M. Balík, J. Rulíšek, P. Kopecký, M. Lipš, O. Šmíd, T. Kovárník, F. Mlejnský, A. Linhart, J. Bělohlávek,
- 520 9_
- $a AIMS: Ventricular septal rupture (VSR) became a rare mechanical complication of myocardial infarction in the era of percutaneous coronary interventions but is associated with extreme mortality in patients who present with cardiogenic shock (CS). Promising outcomes have been reported with the use of circulatory support allowing haemodynamic stabilization, followed by delayed repair. Therefore, we analysed our experience with an early use of Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO) for postinfarction VSR. METHODS AND RESULTS: We conducted a retrospective search of institutional database for patients presenting with postinfarction VSR from January 2007 to June 2016. Data from 31 consecutive patients (mean age 69.5 ± 9.1 years) who were admitted to hospital were analysed. Seven out of 31 patients with VSR who were in refractory CS received V-A ECMO support preoperatively. ECMO improved end-organ perfusion with decreased lactate levels 24 hours after implantation (7.9 mmol/L vs. 1.6 mmol/L, p = 0.01), normalized arterial pH (7.25 vs. 7.40, p < 0.04), improved mean arterial pressure (64 mmHg vs. 83 mmHg, p < 0.01) and lowered heart rate (115/min vs. 68/min, p < 0.01). Mean duration of ECMO support was 12 days, 5 out of 7 patients underwent surgical repair, 4 were weaned from ECMO, 3 survived 30 days and 2 survived more than 1 year. The most frequent complication (5 patients) and the cause of death (3 patients) was bleeding. CONCLUSIONS: Our experience suggests that early V-A ECMO in patients with VSR and refractory CS might prevent irreversible multiorgan failure by improved end-organ perfusion. Bleeding complications remain an important limitation of this approach.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a angiografie $7 D000792
- 650 _2
- $a mimotělní membránová oxygenace $x metody $7 D015199
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a hemodynamika $x fyziologie $7 D006439
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a kardiogenní šok $x etiologie $x patofyziologie $x terapie $7 D012770
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a ruptura komorového septa $x komplikace $x diagnóza $x patofyziologie $7 D018658
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Špunda, Rudolf $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Lindner, Jaroslav $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Rohn, Vilém $u Cardiovascular Surgery Department, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kunstýř, Jan $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Balík, Martin $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Rulíšek, Jan $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $7 xx0224602
- 700 1_
- $a Kopecký, Petr $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Lipš, Michal $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Šmíd, Ondřej $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kovárník, Tomáš $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Mlejnský, František $u 2nd Surgery Department - Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Linhart, Aleš $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Bělohlávek, Jan $u 2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 19 Suppl 2, č. - (2017), s. 97-103
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28470920 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180528160830 $b ABA008
- 999 __
- $a ok $b bmc $g 1288087 $s 1007414
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 19 Suppl 2 $c - $d 97-103 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
- LZP __
- $a Pubmed-20180404